C3-Glomerulonephritis
Die Dense Deposit Disease ist eine glomeruläre Erkrankung der alternativen Complementaktivierung (C3-Glomerulopathie) wo sich die Complement-Ablagerungen mesangial, subendothelial, subepithelial und intramembranös befinden.
Gliederung
![]() |
|||||
![]() |
![]() | ||||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() |
![]() ![]() | |||
![]() |
![]() | ||||
![]() |
![]() |
![]() |
![]() |
![]() |
Referenzen:
1. |
Sánchez-Corral P et al. (2000) Molecular basis for factor H and FHL-1 deficiency in an Italian family. [^] |
2. |
Ault BH et al. (2000) Factor H and the pathogenesis of renal diseases. [^] |
3. |
Pickering MC et al. (2002) Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. [^] |
4. |
Hegasy GA et al. (2002) The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion. [^] |
5. |
Dragon-Durey MA et al. (2004) Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. [^] |
6. |
Abrera-Abeleda MA et al. (2006) Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). [^] |
7. |
Licht C et al. (2006) Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II). [^] |
8. |
Servais A et al. (2007) Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. [^] |
9. |
Levy M et al. (1986) H deficiency in two brothers with atypical dense intramembranous deposit disease. [^] |
10. |
Brai M et al. (1988) Combined homozygous factor H and heterozygous C2 deficiency in an Italian family. [^] |
11. |
Vogt BA et al. (1995) Inherited factor H deficiency and collagen type III glomerulopathy. [^] |
12. |
Høgåsen K et al. (1995) Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. [^] |
13. |
Ault BH et al. (1997) Human factor H deficiency. Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism. [^] |
14. |
Nielsen HE et. al. (1989) Hereditary, complete deficiency of complement factor H associated with recurrent meningococcal disease. [^] |
15. |
Wyatt RJ et al. (1982) Partial H (beta 1H) deficiency and glomerulonephritis in two families. [^] |
16. |
Fijen CA et al. (1996) Heterozygous and homozygous factor H deficiency states in a Dutch family. [^] |
17. |
Welch TR et al. (2002) Complement in glomerulonephritis. [^] |
18. |
Appel GB et al. (2005) Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. [^] |
19. |
Xiao X et. al. (2014) C3 glomerulopathy: the genetic and clinical findings in dense deposit disease and C3 glomerulonephritis. [^] |
20. |
Redahan L et. al. (2014) Familial MPGN - a case series: a clinical description of familial membranoproliferative glomerulonephritis amongst three Irish families. [^] |
21. |
Chen Q et. al. (2014) Complement factor H-related hybrid protein deregulates complement in dense deposit disease. [^] |
22. |
Barbour TD et. al. (2013) Dense deposit disease and C3 glomerulopathy. [^] |